A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008). Nature neuroscience, 11(3), 301308.
α-Synuclein Interacts with Lipoproteins in Plasma. Emamzadeh, F. N., & Allsop, D. (2017). Journal of molecular neuroscience : MN, 63(2), 165172.
Multiple system atrophy and apolipoprotein E. Ogaki, K., Martens, Y. A., Heckman, M. G., Koga, S., Labbé, C., Lorenzo-Betancor, O., Wernick, A. I., Walton, R. L., Soto, A. I., Vargas, E. R., Nielsen, H. M., Fujioka, S., Kanekiyo, T., Uitti, R. J., van Gerpen, J. A., Cheshire, W. P., Wszolek, Z. K., Low, P. A., Singer, W., Dickson, D. W., Ross, O. A. (2018). Movement disorders : official journal of the Movement Disorder Society, 33(4), 647650.
α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients. Paslawski, W., Zareba-Paslawska, J., Zhang, X., Hölzl, K., Wadensten, H., Shariatgorji, M., Janelidze, S., Hansson, O., Forsgren, L., Andrén, P. E., & Svenningsson, P. (2019). Proceedings of the National Academy of Sciences of the United States of America, 116(30), 1522615235.
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid. Zhao, N., Attrebi, O. N., Ren, Y., Qiao, W., Sonustun, B., Martens, Y. A., Meneses, A. D., Li, F., Shue, F., Zheng, J., Van Ingelgom, A. J., Davis, M. D., Kurti, A., Knight, J. A., Linares, C., Chen, Y., Delenclos, M., Liu, C. C., Fryer, J. D., Asmann, Y. W., Bu, G. (2020). Science translational medicine, 12(529).
APOE genotype regulates pathology and disease progression in synucleinopathy. Davis, A. A., Inman, C. E., Wargel, Z. M., Dube, U., Freeberg, B. M., Galluppi, A., Haines, J. N., Dhavale, D. D., Miller, R., Choudhury, F. A., Sullivan, P. M., Cruchaga, C., Perlmutter, J. S., Ulrich, J. D., Benitez, B. A., Kotzbauer, P. T., & Holtzman, D. M. (2020). Science translational medicine, 12(529).
